Dynamic Technology Lab’s Vir Biotechnology VIR Stock Holding History

Dynamic Technology Lab’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,323	Closed	-$182K	–	1118
2026 Q1	$182K	Buy	+20,323	New	+$162K	0.03%	749
2025 Q1	–	Sell	-10,320	Closed	-$76K	–	1386
2024 Q4	$76K	Sell	10,320 -21,580	-68%	-$170K	0.01%	833
2024 Q3	$239K	Buy	31,900 +13,893	+77%	+$121K	0.03%	820
2024 Q2	$160K	Sell	18,007 -6,619	-27%	-$63.5K	0.02%	824
2024 Q1	$250K	Buy	+24,626	New	+$251K	0.03%	847
2023 Q1	–	Sell	-16,240	Closed	-$411K	–	1531
2022 Q4	$411K	Buy	16,240 +5,023	+45%	+$123K	0.04%	662
2022 Q3	$216K	Sell	11,217 -17,813	-61%	-$453K	0.02%	933
2022 Q2	$739K	Buy	29,030 +19,820	+215%	+$463K	0.08%	429
2022 Q1	$237K	Buy	+9,210	New	+$273K	0.03%	887

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Dynamic Technology Lab's VIR Position: Q2 2026 in Review

Dynamic Technology Lab sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 20,323 shares — an estimated $182K sold.

Dynamic Technology Lab first reported a position in VIR in Q1 2022 and held it in 9 quarters. The position peaked at $739K in Q2 2022. 238 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Dynamic Technology Lab reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
Dynamic Technology Lab sold 20,323 Vir Biotechnology shares in Q2 2026, an estimated $182K.
Dynamic Technology Lab first reported a position in Vir Biotechnology in Q1 2022 and held it in 9 quarters.
Dynamic Technology Lab's Vir Biotechnology position peaked at $739K in Q2 2022.
238 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.